Enter your terms above and click the 'Search' button.

Showing articles 0 to 6 of 6 Filter Applied: ipilimumab (Click to remove) Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies Neurol 92:663-674, Johansen, A.,et al, 2019 Immune Checkpoint Inhibitor-Related Myositis and Myocarditis in Patients with Cancer Neurol 91:e985-e994, Touat, M.,et al, 2018 Neurological Immune-Related Adverse Events of Ipilimumab Pract Neurol 13:278-280, Bot, I.,et al, 2013 Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain NEJM 379:722-730,789, Tawbi, H.A.,et al, 2018 Inflammatory Demyelinating Polyneuropathy Versus Leptomeningeal Disease Following Ipilimumab J Immunother Cancer 6:11, Cafuir, L.,et al, 2018 Showing articles 0 to 6 of 6